Want to Participate in a Clinical Trial for Schizophrenia?

Fill out this quick Pre-Screening Questionnaire

Schizophrenia Studies Available to Volunteers

Sponsor: Neurocrine Biosciences

Sponsor: Neurocrine Biosciences

Protocol Number: NBI-98854-ATS3019 & NBI-1065844-CIAS2023

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects With Schizophrenia

Inclusion criteria:

    • Age 18-75
    • Currently being treated with an anti-psychotic medication.
    • Reimbursement for time and travel up to $1,200

Research volunteers play a role in the development of new treatments for some of our most common and debilitating diseases and conditions.

Patients who participate in Excell Research’s clinical trials have an opportunity to join the vanguard of scientific research and contribute to the progress, knowledge, and future treatment of medical conditions.

We will provide you with comprehensive information and straightforward answers to your questions regarding the risks and benefits of participating.

Financial Compensation maybe available to those who qualify

    I identify as:

    Do you currently have, or have you ever had, any of the following?

    How did you hear about us?*



    Pre-Screening Questionnaire and Your Privacy

    Please be advised that by filling out the study pre-screening questionnaire, you will be asked to provide personal information, including age, gender, and your current medical condition. One of our staff will then reach out to conduct a phone-screen to see if you qualify for one of our current studies at our office location in Oceanside, CA. Your privacy is of the utmost importance to Excell Research. Your privacy will be protected and the information you provide will only be shared with those involved with the clinical research study if it is determined that you may be eligible to participate, unless you permit us to do so or except as required by law. Your information will not be sold to outside companies, nor will it be stored or collected without your direct consent.
    Many Pharmaceutical Companies and Excell Research are conducting these studies under the Food and Drug Administration (FDA) to learn more about new investigational drugs or treatments. Read our privacy policy to learn more about how your information will be kept private.


    Resources for Schizophrenia


    Schizophrenia is a mental disorder in which people interpret reality abnormally. Schizophrenia may result in some combination of hallucinations, delusions, and extremely disordered thinking and behavior that impairs daily functioning, and can be disabling.

    Schizophrenia involves a range of problems with thinking (cognition), behavior and emotions. Signs and symptoms may vary, but usually involve delusions, hallucinations or disorganized speech, and reflect an impaired ability to function. Symptoms may include:

    • Delusions. These are false beliefs that are not based in reality.
    • Hallucinations. These usually involve seeing or hearing things that don’t exist.
    • Disorganized thinking (speech). Disorganized thinking is inferred from disorganized speech.
    • Extremely disorganized or abnormal motor behavior. This may show in a number of ways, from childlike silliness to unpredictable agitation. Behavior isn’t focused on a goal, so it’s hard to do tasks. Behavior can include resistance to instructions, inappropriate or bizarre posture, a complete lack of response, or useless and excessive movement.
    • Negative symptoms. This refers to reduced or lack of ability to function normally.